[Systemic aspergillosis].
作者信息
Kashiwagi S
机构信息
Department of General Medicine, Faculty of Medicine, Kyushu University Hospital.
出版信息
Ryoikibetsu Shokogun Shirizu. 1999(24 Pt 2):301-3.
PMID:10201207
Abstract
摘要
相似文献
1
[Systemic aspergillosis].
Ryoikibetsu Shokogun Shirizu. 1999(24 Pt 2):301-3.
2
[Cerebral aspergillosis].
Ryoikibetsu Shokogun Shirizu. 1999(24 Pt 2):304-7.
3
[Pulmonary aspergilloma].
Ryoikibetsu Shokogun Shirizu. 1999(24 Pt 2):308-11.
4
Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus.烟曲霉和黄曲霉在致病性及临床综合征方面的差异。
Med Mycol. 2009;47 Suppl 1:S261-70. doi: 10.1080/13693780802247702. Epub 2008 Jul 24.
5
[Invasive pulmonary aspergillosis].[侵袭性肺曲霉病]
Ryoikibetsu Shokogun Shirizu. 1999(24 Pt 2):312-5.
6
[Allergic bronchopulmonary aspergillosis].
Ryoikibetsu Shokogun Shirizu. 1999(24 Pt 2):319-22.
7
Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.侵袭性曲霉病的治疗失败：两性霉素B治疗后深部组织分离株的敏感性
J Antimicrob Chemother. 2003 Nov;52(5):873-6. doi: 10.1093/jac/dkg434. Epub 2003 Sep 30.
8
[Hepatic aspergillosis].
Ryoikibetsu Shokogun Shirizu. 1999(24 Pt 2):323-4.
9
Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.特比萘芬与两性霉素B联合治疗兔实验性侵袭性曲霉病模型的研究
Antimicrob Agents Chemother. 2005 Nov;49(11):4751-3. doi: 10.1128/AAC.49.11.4751-4753.2005.
10
Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.基于两性霉素B的疗法治疗中枢神经系统曲霉菌病疗效不佳。
Mycoses. 2007 May;50(3):196-200. doi: 10.1111/j.1439-0507.2007.01345.x.
Zotero 插件